Connection

Sheldon Litwin to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Sheldon Litwin has written about Drug Resistance, Neoplasm.
Sheldon Litwin
Connection Strength
0.020
Drug Resistance, Neoplasm
  1. Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib. Cancer Chemother Pharmacol. 2012 Apr; 69(4):977-82.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.